Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Immedica Pharma AB

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 1,168,112 Less Arrow 917,236 Less Arrow 576,611
Financial expenses 130,417 Less Arrow 72,208 More Arrow 72,998
Earnings before taxes -107,107 More Arrow 84,665 Less Arrow 30,845
EBITDA 138,612 More Arrow 235,987 Less Arrow 176,710
Total assets 2,489,717 Less Arrow 2,254,869 Less Arrow 1,454,806
Current assets 771,119 Less Arrow 594,555 Less Arrow 326,752
Current liabilities 409,677 Less Arrow 340,123 Less Arrow 160,302
Equity capital 893,852 Less Arrow 840,981 Less Arrow 623,594
- share capital 52 Less Arrow 51 Less Arrow 47
Employees (average) 69 More Arrow 88 Less Arrow 69

Financial ratios

Fiscal year 2024/12 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 35.9% More Arrow 37.3% More Arrow 42.9%
Turnover per employee 16,929 Less Arrow 10,423 Less Arrow 8,357
Profit as a percentage of turnover -9.2% More Arrow 9.2% Less Arrow 5.3%
Return on assets (ROA) 0.9% More Arrow 7.0% More Arrow 7.1%
Current ratio 188.2% Less Arrow 174.8% More Arrow 203.8%
Return on equity (ROE) -12.0% More Arrow 10.1% Less Arrow 4.9%
Change turnover
Change turnover % 49% Less Arrow 23%
Chg. No. of employees
Chg. No. of employees % 28% More Arrow 33%

Total value of public sale

Fiscal year 2024/12 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.